Background
==========

ASSIT is a novel therapy of allergic diseases that gained significant acceptance over the past decade. This study was undertaken to investigate whether ASSIT in PAR may influence the Intracellular expression of IFN- gamma and IL-4 by CD3+CD8+ T-cells.

Subjects and methods
====================

Twenty adult PAR patients sensitive only to the mite D.farinae as diagnosed by Prick skin testing (PST) \[Omega labs, Montreal, Canada\] were included in the study. ASSIT to D. farinae was administered for 6 months.

Flow cytometric evaluation of the intracellular expression of IL-4 and IFN- gamma by CD3+ CD8+ T-cells was determined according to Manufacturer instructions (Beckton Dickenson) before and after ASSIT.

The total 5 symptom score (T5SS) of PAR and the diameter of PST were also examined.

Results
=======

After ASSIT; the percentage of Il-4 expressing CD8+ T-cells significantly decreased from \[0.69 +/- 0.18\] to \[0.33 +/- 0.13\] and the percentage of IFN-gamma expressing CD8+ T-cells significantly increased from \[4.63 +/- 1.29\] to \[7.20 +/- 2.09\]. The T5SS and the PST diameter also significantly decreased.

Conclusion
==========

In this study the favorable clinical response induced by ASSIT in PAR correlated with the decrease in the percentage of Tc2 cells and the increase in the percentage of Tc1 cells.
